Heartbeam Inc (BEAT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Heartbeam Inc (BEAT) has a cash flow conversion efficiency ratio of -5.685x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.61 Million) by net assets ($635.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BEAT equity to assets ratio to measure how much of total assets are equity-financed.
Heartbeam Inc - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Heartbeam Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Heartbeam Inc to evaluate the quality of earnings relative to operating cash generation.
Heartbeam Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Heartbeam Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Viomi Technology ADR
NASDAQ:VIOT
|
-0.320x |
|
Lantern Pharma Inc
NASDAQ:LTRN
|
-0.477x |
|
Y-S Electronic Co Ltd
TWO:6418
|
0.020x |
|
Freemelt Holding AB
ST:FREEM
|
-0.037x |
|
Royalty Management Holding Corporation
NASDAQ:RMCO
|
0.002x |
|
NXT Energy Solutions Inc
TO:SFD
|
-0.136x |
|
Myomo Inc
NYSE MKT:MYO
|
-0.244x |
|
InspireMD Inc
NASDAQ:NSPR
|
-0.283x |
Annual Cash Flow Conversion Efficiency for Heartbeam Inc (2006–2025)
The table below shows the annual cash flow conversion efficiency of Heartbeam Inc from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Heartbeam Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.60 Million | $-13.99 Million | -5.374x | +38.58% |
| 2024-12-31 | $1.65 Million | $-14.47 Million | -8.749x | -1053.02% |
| 2023-12-31 | $15.94 Million | $-12.09 Million | -0.759x | +81.89% |
| 2022-12-31 | $2.37 Million | $-9.95 Million | -4.190x | -1639.73% |
| 2021-12-31 | $13.41 Million | $-3.23 Million | -0.241x | -292.09% |
| 2020-12-31 | $-4.79 Million | $-600.00K | 0.125x | +114.37% |
| 2019-12-31 | $-3.73 Million | $-218.00K | 0.058x | -75.04% |
| 2018-12-31 | $310.49 Million | $72.75 Million | 0.234x | +146.00% |
| 2017-12-31 | $249.70 Million | $23.78 Million | 0.095x | -65.95% |
| 2016-12-31 | $138.91 Million | $38.85 Million | 0.280x | +47.98% |
| 2015-12-31 | $75.93 Million | $14.35 Million | 0.189x | +36.59% |
| 2014-12-31 | $63.68 Million | $8.81 Million | 0.138x | -17.87% |
| 2013-12-31 | $66.83 Million | $11.26 Million | 0.168x | +105.34% |
| 2012-12-31 | $70.00 Million | $5.74 Million | 0.082x | +27.22% |
| 2011-12-31 | $78.00 Million | $5.03 Million | 0.064x | -16.03% |
| 2010-12-31 | $134.93 Million | $10.36 Million | 0.077x | +45.11% |
| 2009-12-31 | $149.35 Million | $7.90 Million | 0.053x | -22.93% |
| 2008-12-31 | $150.12 Million | $10.31 Million | 0.069x | +676.27% |
| 2007-12-31 | $-26.87 Million | $-237.64K | 0.009x | -93.97% |
| 2006-12-31 | $-19.86 Million | $-2.91 Million | 0.147x | -- |
About Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection … Read more